Neuropsychiatric symptoms in Alzheimer disease (AD) cause significant distress and present a complex clinical challenge for treatment. Pharmacological treatment options are limited to antipsychotics, which carry extensive safety issues. There is emerging evidence to support the potential benefits of memant...
To establish the mortality risk and adverse events associated with the use of atypical antipsychotic medications in people with Parkinson disease psychosis (PDP) in a clinically defined trial cohort.
To compare health care and home care service utilization, mortality, and long-term care admissions between long-term opioid users and nonusers among aged home care clients.
Contact the Centers for Medicare & Medicaid Services regarding recent reductions to Practice Expense (PE) RVUs for services in Skilled Nursing Facilities (POS 31). These cuts create an artificial payment difference that does not reflect clinical reality. There is no meaningful difference in the cost of...